Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OA-INULIN: Inulin Supplementation for Knee Osteoarthritis
NCT07189585Phase 2Not yet recruiting
- Sponsor
- Yale University
- Start
- Nov 2026
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of inulin in knee osteoarthritis (OA) (3 arms), sponsored by Yale University. Primary endpoint: Change in serum lipopolysaccharide concentration at 8 weeks. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
inulin
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT07189585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07189585.